[
  {
    "ts": null,
    "headline": "Merck: Don't Fight The Tape, How Low Can It Go?",
    "summary": "Financial writer advises caution on investing in Merck & Co., Inc. due to negative sentiment and potential price declines. Click for more on MRK Q4 earnings.",
    "url": "https://finnhub.io/api/news?id=8efcc3c20d2667e09cec883be62478cd5f14ac891b3fb1081d4de29b57f647f9",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738776499,
      "headline": "Merck: Don't Fight The Tape, How Low Can It Go?",
      "id": 132568610,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/155351397/image_155351397.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Financial writer advises caution on investing in Merck & Co., Inc. due to negative sentiment and potential price declines. Click for more on MRK Q4 earnings.",
      "url": "https://finnhub.io/api/news?id=8efcc3c20d2667e09cec883be62478cd5f14ac891b3fb1081d4de29b57f647f9"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer : Announces New Chief Oncology Officer",
    "summary": "Wednesday, February 05, 2025 - 04:45pm Share  New York, February 5, 2025 - Pfizer Inc. today announced that Jeffrey Legos, PhD, MBA, will join the company as Chief Oncology Officer. In...",
    "url": "https://finnhub.io/api/news?id=924e95cd0f3e577206ce03044d196d84fab25b23464168420aa53061261187f6",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738775282,
      "headline": "Pfizer : Announces New Chief Oncology Officer",
      "id": 132568460,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "Wednesday, February 05, 2025 - 04:45pm Share  New York, February 5, 2025 - Pfizer Inc. today announced that Jeffrey Legos, PhD, MBA, will join the company as Chief Oncology Officer. In...",
      "url": "https://finnhub.io/api/news?id=924e95cd0f3e577206ce03044d196d84fab25b23464168420aa53061261187f6"
    }
  },
  {
    "ts": null,
    "headline": "These S&P 500 Stocks Yield 6%. They Could Be Better Than Bonds.",
    "summary": "These S&P 500 Stocks Yield 6%. They Could Be Better Than Bonds.",
    "url": "https://finnhub.io/api/news?id=7af2ceb7f611d88cb961dee9842e168541fda89452f82bd609a59ee0a265ddf7",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738770300,
      "headline": "These S&P 500 Stocks Yield 6%. They Could Be Better Than Bonds.",
      "id": 132575688,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "These S&P 500 Stocks Yield 6%. They Could Be Better Than Bonds.",
      "url": "https://finnhub.io/api/news?id=7af2ceb7f611d88cb961dee9842e168541fda89452f82bd609a59ee0a265ddf7"
    }
  },
  {
    "ts": null,
    "headline": "MoneyShow's Best Investment Ideas For 2025: Part 9",
    "summary": "MoneyShow presents top investment ideas for 2024 from leading advisors. Part 8 includes Lara Exploration, Imperial Oil, Avino Silver & Gold Mines, BBB Foods and Pfizer, among others.",
    "url": "https://finnhub.io/api/news?id=4edf1acd12415442744fb6eff73d544617a36df76a0940166704fb7f7f1ed62a",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738751700,
      "headline": "MoneyShow's Best Investment Ideas For 2025: Part 9",
      "id": 132562886,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1312768788/image_1312768788.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "MoneyShow presents top investment ideas for 2024 from leading advisors. Part 8 includes Lara Exploration, Imperial Oil, Avino Silver & Gold Mines, BBB Foods and Pfizer, among others.",
      "url": "https://finnhub.io/api/news?id=4edf1acd12415442744fb6eff73d544617a36df76a0940166704fb7f7f1ed62a"
    }
  },
  {
    "ts": null,
    "headline": "Merck Is Suffering From a Classic Pharma Problem",
    "summary": "Merck Is Suffering From a Classic Pharma Problem",
    "url": "https://finnhub.io/api/news?id=9c176806575301aa39a2825c11115e2067f62d0cadf52008873bf924f3d6328e",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738738800,
      "headline": "Merck Is Suffering From a Classic Pharma Problem",
      "id": 132564431,
      "image": "",
      "related": "PFE",
      "source": "DowJones",
      "summary": "Merck Is Suffering From a Classic Pharma Problem",
      "url": "https://finnhub.io/api/news?id=9c176806575301aa39a2825c11115e2067f62d0cadf52008873bf924f3d6328e"
    }
  }
]